1 min readAs we review the overall numbers for Q1 ’25, we see a tale of two markets – technology and healthcare. Tech market deal value of $11.5 billion remains very healthy relative to historical quarterly value numbers. Healthcare, on the other hand, hit a new quarterly low in deal value of just $400 million. Notably, despite…
1 min readWelcome to our Q4 and full year 2024 review of the venture debt market. The numbers are in and by “most” accounts, venture debt had a booming fourth quarter in 2024 and a record full year in terms of deal volume. While some of these record numbers were skewed higher by a handful of mega…
3 min readAfter two years of a relatively lackluster funding environment in the life sciences and biotech sectors, we were eager to kick off the new year with our annual visit to San Francisco for the 43rd Annual J.P. Morgan Healthcare Conference (#JPM2025). As a registered investment advisor and an advisor on venture debt financing for life…
1 min readAs we review the numbers for the venture debt market in Q3 2024, we see a bit of a mixed bag of data. On a positive note, the healthcare market reached heights in deal volume (capital deployed) that we haven’t seen in more than three years. However, the total deal count to reach these numbers…